Clinical predictive factors of the efficacy of immune checkpoint inhibitors and kinase inhibitors in advanced hepatocellular cancer
Article in Clinical and Translational Oncology (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study
Article in Frontiers in Oncology (January 2024)
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients
Article in Scientific Reports (July 2023)